Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Trial Profile

BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 28 Apr 2017 Preliminary results of this trial assessing safety and efficacy presented at the 69th Annual Meeting of the American Academy of Neurology.
    • 20 Apr 2017 According to an Allergan media release, data from this study will be presented at the upcoming 69th American Academy of Neurology (AAN) annual meeting.
    • 02 Oct 2015 Planned end date changed from 1 Mar 2016 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top